Global Oncology Nutrition Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Cancer Type;
Head & Neck Cancer, Stomach & Gastrointestinal Cancers, Blood Cancer, Breast Cancer, Lung Cancer, and Other cancers.By End Use;
Hospitals & Clinics, Home Care, and Others.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).Introduction
Global Oncology Nutrition Market (USD Million), 2021 - 2031
In the year 2024, the Global Oncology Nutrition Market was valued at USD 2,140.29 million. The size of this market is expected to increase to USD 3,862.56 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 8.8%.
The global oncology nutrition market is witnessing significant growth driven by an increase in cancer prevalence worldwide and a growing recognition of the importance of nutritional support in cancer treatment. Cancer patients often experience malnutrition due to the disease itself or side effects of treatments such as chemotherapy and radiation therapy. This has led to a heightened focus on specialized nutrition products tailored to meet the unique dietary needs of cancer patients. These products aim to provide essential nutrients, manage symptoms, and improve patients' overall quality of life during treatment.
Advancements in medical research and technology have led to the development of innovative nutritional formulations specifically designed for various stages and types of cancer. These products not only address malnutrition but also target specific nutritional deficiencies commonly observed in cancer patients, such as protein-energy malnutrition and micronutrient deficiencies. Additionally, increasing collaborations between healthcare providers, nutritionists, and pharmaceutical companies have resulted in the development of comprehensive oncology nutrition programs aimed at optimizing patient outcomes and reducing treatment-related complications.
Rising healthcare expenditure, growing awareness about the importance of nutrition in cancer management among both patients and healthcare professionals, and initiatives by government and non-government organizations to improve cancer care infrastructure are contributing to the expansion of the oncology nutrition market globally. Additionally, the integration of nutrition therapy into standard cancer care protocols and the incorporation of nutritional assessment and intervention as part of routine cancer management practices are expected to further drive market growth in the coming years.
Global Oncology Nutrition Market Recent Developments
- July 2022: Nestle launched China's first Foods for Special Medical Purpose (FSMP) for patients suffering from tumor-related conditions, after going through a five-year-long approval process from the Chinese regulator.
- January 2022: Faeth Therapeutics closed a USD 47 million Series A round of private financing led by S2G Ventures, bringing total funding to date to USD 67 million. The money from the financing will be used to move forward with Faeth's clinical trials, which use a combination of nutrient control, drugs, and digital tools to stop cancer from growing.
Segment Analysis
The Global Oncology Nutrition Market is segmented by cancer type, which significantly influences the nutritional needs and management strategies for patients. Head & neck cancer patients often face challenges such as difficulty swallowing and oral complications due to surgery or radiation therapy, which can lead to malnutrition. Specialized nutritional products, including liquid supplements and enteral feeding, are crucial for supporting these patients throughout their treatment. Similarly, stomach and gastrointestinal cancers impact the body's ability to absorb nutrients, making nutritional support a vital component of treatment. Specialized formulas are often required to address issues like nausea, vomiting, and malabsorption, helping to maintain strength and prevent weight loss. Blood cancer patients, particularly those undergoing chemotherapy, often struggle with fatigue, weight loss, and diminished appetite, requiring targeted nutritional support to maintain energy levels and support the immune system.
The breast cancer segment is another key area in the oncology nutrition market, as breast cancer treatments, such as chemotherapy and hormone therapy, can lead to side effects like appetite loss, nausea, and weight fluctuations. Nutritional support is crucial to help manage these effects, improving patient quality of life and promoting recovery. Lung cancer also represents a significant portion of the market, as patients with this type of cancer often experience significant weight loss, fatigue, and difficulty eating, especially in advanced stages. Nutritional interventions that provide essential nutrients in easy-to-digest formats are vital for managing these challenges. The other cancers category includes rare cancers such as ovarian, pancreatic, and liver cancers, which also require specialized nutritional solutions tailored to the unique effects of the treatments and the cancer itself.
In terms of end use, the market is divided into hospitals & clinics, home care, and others. Hospitals and clinics are major settings for oncology nutrition, as they provide the necessary infrastructure for delivering personalized nutrition care, including parenteral and enteral nutrition. Nutritional interventions in these settings are essential during chemotherapy, surgery, and recovery phases to ensure patients receive adequate caloric and protein intake. Home care is a growing segment, particularly as cancer patients increasingly receive treatment in their homes. Home-based nutrition services, including meal delivery programs, oral nutritional supplements, and enteral feeding, are essential for patients managing treatment side effects while maintaining their quality of life. The others category includes long-term care facilities and rehabilitation centers, where oncology nutrition is crucial for improving patient outcomes and supporting recovery. As personalized care becomes more prevalent, the oncology nutrition market continues to expand in these various end-user settings, ensuring that patients receive appropriate support throughout their treatment journey.
Global Oncology Nutrition Segment Analysis
In this report, the Global Oncology Nutrition Market has been segmented by Cancer Type, End Use, and Geography.
Global Oncology Nutrition Market, Segmentation by Cancer Type
The Global Oncology Nutrition Market has been segmented by Cancer Type into Head & Neck Cancer, Stomach & Gastrointestinal Cancers, Blood Cancer, Breast Cancer, Lung Cancer, and Other cancers.
The Global Oncology Nutrition Market is segmented by cancer type, which plays a crucial role in determining the nutritional needs and support required by patients undergoing cancer treatment. Head & neck cancer is one of the significant segments in this market, as patients with these types of cancer often face challenges in maintaining adequate nutrition due to difficulties in swallowing and chewing, which require specialized nutritional formulas and feeding strategies. Nutrition plays a key role in supporting the immune system and ensuring better outcomes during treatments like surgery, chemotherapy, or radiation, making oncology nutrition essential for these patients.
Stomach and gastrointestinal cancers also represent a substantial segment in the oncology nutrition market, as these cancers often affect the digestive system, leading to malnutrition, weight loss, and a decreased ability to absorb essential nutrients. For patients with gastrointestinal cancers, targeted nutrition solutions are critical to address these challenges, providing essential nutrients in easily digestible forms to support healing and prevent malnutrition. In addition, blood cancer (such as leukemia and lymphoma) patients also face unique nutritional requirements, as treatments like chemotherapy and radiation can significantly affect the body's ability to metabolize and absorb nutrients, necessitating specialized nutritional interventions to maintain energy levels and support recovery.
Breast cancer and lung cancer are other key segments in the oncology nutrition market. For breast cancer patients, nutritional strategies are vital for managing the side effects of chemotherapy, radiation, and hormonal therapies, which can lead to appetite loss, nausea, and fatigue. Nutritional support helps to mitigate these effects and improve quality of life during treatment. Similarly, lung cancer patients often experience weight loss, loss of appetite, and muscle wasting, especially in advanced stages. Specific nutritional solutions for lung cancer patients are designed to help them maintain strength and energy throughout their treatment. The other cancers category includes a wide variety of less common cancers, such as ovarian, pancreatic, and prostate cancers, all of which have unique nutritional needs due to their different treatment protocols and effects on the body. The increasing focus on personalized nutrition based on cancer type drives the growth of the oncology nutrition market, ensuring that patients receive tailored support to improve their overall treatment outcomes.
Global Oncology Nutrition Market, Segmentation by End Use
The Global Oncology Nutrition Market has been segmented by End Use into Hospitals & Clinics, Home Care, and Others.
The Global Oncology Nutrition Market is segmented by end use, which highlights the various settings where oncology nutrition plays a crucial role in patient care. Hospitals and clinics represent the largest segment, as they are the primary care settings for cancer patients undergoing treatments like chemotherapy, radiation, or surgery. In these facilities, oncology nutrition is essential to manage the side effects of treatment, such as nausea, fatigue, and loss of appetite. Hospitals and clinics offer both inpatient and outpatient care, providing targeted nutritional support through specialized diets, enteral and parenteral feeding, and oral nutritional supplements. These nutritional interventions help to maintain energy levels, prevent malnutrition, and improve overall treatment outcomes, ensuring that cancer patients can better tolerate their therapies and recover more effectively.
The home care segment is growing rapidly within the oncology nutrition market, driven by the increasing preference for receiving care at home and advancements in home healthcare services. Cancer patients often experience prolonged treatment periods, and home care services provide personalized nutritional support in a more comfortable, familiar environment. Services such as home delivery of nutritional supplements, enteral feeding, and telemedicine consultations with dietitians and nutritionists allow patients to manage their dietary needs without frequent hospital visits. Home care nutrition is particularly important for patients with advanced cancer or those in palliative care, as it ensures they maintain adequate nutrition and hydration, helping to improve their quality of life while reducing the burden on healthcare facilities.
The others category in the end-use segmentation includes long-term care facilities, rehabilitation centers, and specialized cancer treatment centers, all of which require oncology nutrition services. In these settings, patients who are undergoing rehabilitation or are in need of extended care after cancer treatment still face challenges related to nutrition. These facilities provide customized nutritional care to address the unique needs of cancer survivors and patients in recovery, including nutritional therapy to support healing, muscle mass preservation, and immune function. As cancer treatments become more personalized, and as patients live longer with cancer, the demand for oncology nutrition across these varied care settings continues to grow, ensuring that patients receive the ongoing support they need to thrive.
Global Oncology Nutrition Market, Segmentation by Geography
In this report, the Global Oncology Nutrition Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Oncology Nutrition Market Share (%), by Geographical Region, 2024
In 2023, the global oncology nutrition market witnessed significant distribution across various geographical regions. North America held a substantial share, commanding a leading position in the market. The region's dominance can be attributed to advanced healthcare infrastructure, increasing prevalence of cancer, and high awareness regarding the importance of proper nutrition in cancer management. Additionally, the presence of key market players and ongoing research and development activities contributed to the region's market share.
Following North America, Europe emerged as another prominent market for oncology nutrition. Factors such as rising cancer incidence, favorable government initiatives, and growing adoption of specialized nutrition products in cancer care drove the market growth in this region. Moreover, collaborations between healthcare organizations and nutrition companies aimed at providing tailored nutrition solutions further bolstered the market expansion in Europe.
Asia Pacific exhibited significant potential in the oncology nutrition market, with a notable share in 2023. The region's market growth was fueled by increasing investments in healthcare infrastructure, rising disposable income, and growing awareness about the importance of nutrition in cancer treatment and recovery. Moreover, the presence of a large patient pool and evolving healthcare policies contributed to the expanding market share of oncology nutrition products in Asia Pacific.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Oncology Nutrition Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers
- Increasing prevalence of cancer worldwide
-
Rising awareness about the importance of nutrition in cancer treatment - The global oncology nutrition market is experiencing significant growth, driven by rising awareness about the crucial role of nutrition in cancer treatment. As the understanding of the intricate relationship between diet and cancer therapy improves, healthcare professionals and patients alike are recognizing the importance of personalized nutrition interventions to complement traditional treatment modalities. This heightened awareness stems from the growing body of research demonstrating how proper nutrition can help mitigate treatment side effects, enhance treatment efficacy, and improve overall quality of life for cancer patients.
The increasing prevalence of cancer worldwide has placed a spotlight on the need for comprehensive oncology care, including nutritional support. With cancer rates on the rise globally, healthcare systems are under pressure to provide holistic care that addresses not only the disease itself but also the various challenges patients face throughout their treatment journey. In this context, oncology nutrition has emerged as a critical component of supportive care, with a focus on optimizing nutritional status to better equip patients to tolerate treatment, prevent malnutrition, and maintain strength and immunity.
Technological advancements and innovations in the field of oncology nutrition are driving market growth. From personalized nutrition plans tailored to individual patient needs to novel nutritional supplements specifically formulated for cancer patients, there is a growing array of tools and resources available to support oncology nutrition care. Additionally, the integration of digital health solutions, such as mobile apps and telemedicine platforms, is making it easier for patients to access nutritional guidance and support remotely, thereby enhancing the scalability and reach of oncology nutrition services.
Restraints
- High cost of specialized oncology nutrition products
-
Limited access to oncology nutrition services in certain regions -The global oncology nutrition market is witnessing significant growth, driven by the increasing prevalence of cancer worldwide. Proper nutrition plays a crucial role in managing the treatment and side effects of cancer therapies, thereby improving patients' overall quality of life. However, despite the growing demand for oncology nutrition services, access remains limited in certain regions, posing a challenge to effective cancer care delivery.
One of the primary reasons for limited access to oncology nutrition services in certain regions is inadequate healthcare infrastructure and resources. Many low- and middle-income countries struggle to provide comprehensive cancer care due to limited funding, shortage of healthcare professionals, and insufficient facilities. As a result, patients in these regions often face barriers in accessing specialized oncology nutrition support.
Socioeconomic factors such as poverty, lack of education, and unequal distribution of resources contribute to disparities in access to oncology nutrition services. Patients from marginalized communities or remote areas may face additional challenges in accessing adequate nutrition support during their cancer journey. Without proper nutrition, cancer patients are at a higher risk of malnutrition, treatment complications, and poorer outcomes.
Opportunities
- Advancements in nutritional science and technology
-
Growing demand for personalized nutrition solutions for cancer patients - The global oncology nutrition market is experiencing a surge in demand driven by the growing recognition of the importance of personalized nutrition solutions for cancer patients. As the understanding of cancer biology advances, there is a growing realization that nutrition plays a crucial role in supporting patients through their treatment journey. Personalized nutrition takes into account the unique needs of each patient, considering factors such as their specific type of cancer, treatment regimen, metabolic profile, and dietary preferences.
One of the key drivers behind the demand for personalized oncology nutrition solutions is the increasing prevalence of cancer worldwide. With cancer rates on the rise and a growing emphasis on improving patient outcomes and quality of life, healthcare providers are turning to nutrition as an essential component of comprehensive cancer care. Research continues to uncover the intricate links between diet, metabolism, and cancer progression, further highlighting the importance of tailored nutrition interventions.
Another factor fueling the growth of the oncology nutrition market is the rise of precision medicine and targeted therapies. These advancements have led to more targeted and effective treatments for cancer, but they also underscore the need for personalized supportive care, including nutrition. Nutritional interventions tailored to the individual characteristics of patients can help mitigate treatment side effects, optimize response to therapy, and improve overall well-being.
Competitive Landscape Analysis
Key players in Global Oncology Nutrition Market include :
- Nestlé Health Science
- Abbott Laboratories
- Danone SA
- Fresenius Kabi AG
- Mead Johnson Nutrition Company (a subsidiary of Reckitt Benckiser Group plc)
- B. Braun Melsungen AG
- Hormel Foods Corporation
- Meiji Holdings Co., Ltd.
- Global Healing Center
- FMC Corporation
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Cancer Type
- Market Snapshot, By End Use
- Market Snapshot, By Region
- Global Oncology Nutrition Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Increasing prevalence of cancer worldwide
- Rising awareness about the importance of nutrition in cancer treatment
- Restraints
- High cost of specialized oncology nutrition products
- Limited access to oncology nutrition services in certain regions
- Opportunities
- Advancements in nutritional science and technology
- Growing demand for personalized nutrition solutions for cancer patient
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Oncology Nutrition Market, By Cancer Type, 2021 - 2031 (USD Million)
- Head & Neck Cancer
- Stomach & Gastrointestinal Cancers
- Blood Cancer
- Breast Cancer
- Lung Cancer
- Other cancers
- Global Oncology Nutrition Market, By End Use, 2021 - 2031 (USD Million)
- Hospitals & Clinics
- Home Care
- Others
- Global Oncology Nutrition Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Oncology Nutrition Market, By Cancer Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Nestlé Health Science
- Abbott Laboratories
- Danone SA
- Fresenius Kabi AG
- Mead Johnson Nutrition Company (a subsidiary of Reckitt Benckiser Group plc)
- B. Braun Melsungen AG
- Hormel Foods Corporation
- Meiji Holdings Co., Ltd.
- Global Healing Center
- FMC Corporation
- Company Profiles
- Analyst Views
- Future Outlook of the Market